Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma
Clinical trial NCT06730542 · RECRUITING
Trial details
- NCT number
- NCT06730542
- Sponsor
- Juan P. Alderuccio, MD
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-17
- Primary completion
- 2030-04-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.